Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Taste Technology Company Receives Funding For Further Research To Eliminate Bitter Taste In Oral Medicines

By Pharmaceutical Processing | January 27, 2004

Linguagen Corp. a developer of ingredients used to improve the taste of pharmaceuticals, foods, and beverages, has received a commitment of $10.2 million in new equity financing. Participating in the first round financing were NJTC Venture Fund SBIC, L.P, Cargill Ventures, Danisco Venture A/S (Danisco A/S), DuPont Ventures, Aperture Venture Partners LLC, and RK Ventures Group, LLC.

The funding will be used to expand Linguagen’s taste receptor research for solving problems associated with bitterness, too much salt, and too much sugar, and to commercialize products and systems that are developed. The participation of three of the world’s leading food ingredients companies in Cargill, Danisco, and DuPont will bring not just financial resources to the effort but also greater insight into trends and needs of the food industry.

“We are pleased at the high level of confidence our investors have shown in Linguagen’s research and strategic plan for applying our technology in the emerging field of taste signaling,” said Shawn M. Marcell, Linguagen’s COO and acting CEO. “The investor syndicate includes well-known players in the venture capital, food, and pharmaceutical industries, and we are pleased to have their collective experience as we move the company forward into its next phase of growth. We plan to use this funding to aggressively develop our research and to meet the needs of our expanding customer base.”

Linguagen uses innovative, proprietary biotechnology to discover natural ingredients that improve the flavor of pharmaceuticals and the flavors and health values of foods and beverages. Traditionally bitterness is masked by adding large quantities of sugar, salt, flavorings, or coating agents. Linguagen has developed technology to identify compounds that selectively eliminate the perception of bitterness so that products would require less sugar, salt, or flavorings, resulting in products that taste better and are healthier. The Company’s first product, AMP, has recently completed GRAS (Generally Recognized as Safe) regulatory approval process in the U.S. for use in coffee and tea beverages, artificial sweeteners, chewing gum, salty snack foods, salt substitutes, and soup products and is currently being evaluated by a number of companies for use in their products. Linguagen’s science is also being applied to discover superior natural sugar and salt substitutes and to enhance the sweetness of natural sugar.

Related Articles Read More >

Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE